Stem cell transplant and Gastroenteritis norovirus
Summary:
Gastroenteritis norovirus is found among people with Stem cell transplant, especially for people who are male, 30-39 old.
The study analyzes which people have Gastroenteritis norovirus with Stem cell transplant. It is created by eHealthMe based on reports of 27 people who have Stem cell transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Stem cell transplant?
Stem cell transplant is found to be associated with 431 drugs and 382 conditions by eHealthMe. Check the latest studies of Stem cell transplant.
What is Gastroenteritis norovirus?
Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection) is found to be associated with 224 drugs and 345 conditions by eHealthMe. Check the latest studies of Gastroenteritis norovirus.
27 people who have Stem Cell Transplant and Gastroenteritis Norovirus are studied.

Gender of people who have Stem Cell Transplant and experienced Gastroenteritis Norovirus *:
- female: 28 %
- male: 72 %
Age of people who have Stem Cell Transplant and experienced Gastroenteritis Norovirus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 20 %
- 20-29: 0.0 %
- 30-39: 24 %
- 40-49: 20 %
- 50-59: 16 %
- 60+: 20 %
Common co-existing conditions for these people *:
- Hiv Infection: 2 people, 7.41%
- Mycobacterium Test Positive: 1 person, 3.70%
- Immunodeficiency Disorders: 1 person, 3.70%
- Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 1 person, 3.70%
- Bone Marrow Conditioning Regimen: 1 person, 3.70%
- Adenovirus Infection: 1 person, 3.70%
- Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 3.70%
Common drugs taken by these people *:
- Cyclosporine: 16 people, 59.26%
- Prednisolone: 12 people, 44.44%
- Mycophenolate Mofetil: 8 people, 29.63%
- Fludarabine Phosphate: 4 people, 14.81%
- Melphalan Hydrochloride: 3 people, 11.11%
- Tacrolimus: 3 people, 11.11%
- Melphalan: 2 people, 7.41%
- Cyclophosphamide: 2 people, 7.41%
- Methotrexate: 2 people, 7.41%
- Methylprednisolone: 2 people, 7.41%
Common symptoms for these people *:
- Diarrhea: 10 people, 37.04%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 9 people, 33.33%
- Nausea (feeling of having an urge to vomit): 9 people, 33.33%
- Nausea And Vomiting: 8 people, 29.63%
- Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 4 people, 14.81%
- Acute Graft Versus Host Disease In Intestine (acute complication in intestine following an allogeneic tissue/blood transplant): 3 people, 11.11%
- Adenovirus Infection: 3 people, 11.11%
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 3 people, 11.11%
- Fever: 2 people, 7.41%
- Idiopathic Pneumonia Syndrome (pneumonia-like symptoms): 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Gastroenteritis norovirus?
- Check whether Gastroenteritis norovirus is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Stem cell transplant (13,935 reports)
- Gastroenteritis norovirus (1,661 reports)
All the drugs that are associated with Gastroenteritis norovirus:
- Gastroenteritis norovirus (224 drugs)
All the conditions that are associated with Gastroenteritis norovirus:
- Gastroenteritis norovirus (345 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Gastroenteritis norovirus and Stem cell transplant, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mirena and Muscle Spasms for Women aged 50-59 - 2 seconds ago
- Mirena and Muscle Spasm for Women aged 50-59 - 2 seconds ago
- Could Vinorelbine cause Diffuse Large B-Cell Lymphoma Recurrent? - 9 seconds ago
- Rashes and Seizures - 13 seconds ago
- Could Faslodex cause Face Injury? - 16 seconds ago
- Constipation and drugs of ingredients of letrozole - 17 seconds ago
- Could Loperamide Hydrochloride cause Yellow Skin? - 18 seconds ago
- Could Hydrochlorothiazide cause Arthropathy? - 21 seconds ago
- Could Tadalafil cause Renal Cyst? - 21 seconds ago
- Could Xopenex cause Nosebleed? - 25 seconds ago